Related Experiment Video
Updated: Jun 22, 2026

An Optimized Protocol for Candida albicans Infection in Schmidtea mediterranea to Study Fungal Pathogenesis and Host Defense
Published on: April 17, 2026
Candidal onychomycosis: a mini-review
J A M S Jayatilake1, W M Tilakaratne, G J Panagoda
1Division of Microbiology, Department of Oral Medicine and Periodontology, Faculty of Dental Sciences, University of Peradeniya, Peradeniya, Sri Lanka. sumedhaj@pdn.ac.lk
Abstract:
Onychomycosis is a common fungal infection affecting nails. The primary cause for onychomycosis is dermatophytes, while Candida species have emerged as second-line pathogens. Onychomycosis due to Candida (candidal onychomycosis) is increasingly found in individuals having defective immunity consequential to aging, diabetes mellitus, vascular diseases, HIV infection and drug therapies such as immunosuppressives and broad-spectrum antibiotics. Breached local immunity at the nail complex due to trauma, chronic exposure to moisture and chemicals including smoke, detergents, soap, etc., also contribute to candidal onychomycosis. Adhesion, filamentation, secretion of extracellular enzymes and the development of antifungal resistance are some of the virulence mechanisms of Candida species associated with onychomycosis. Diagnosis of onychomycosis depends on history and clinical examination, direct microscopic investigation, mycological culture and histopathology. Restoration of immune defenses, elimination of fungi using appropriate drug therapy and improvement of nail hygiene with the removal of predisposing factors are key aspects in the management of candidal onychomycosis.
Insights
Candidal onychomycosis, a fungal nail infection, is increasingly prevalent in immunocompromised individuals. Effective management involves immune support, antifungal treatment, and addressing predisposing factors for nail health.
Area of Science:
- Medical Mycology
- Dermatology
- Infectious Diseases
Background:
- Onychomycosis is a prevalent fungal nail infection, primarily caused by dermatophytes.
- Candida species are emerging as significant secondary pathogens in onychomycosis.
- Candidal onychomycosis disproportionately affects individuals with compromised immunity due to aging, diabetes, HIV, and certain medications.
Purpose of the Study:
- To review the epidemiology, pathogenesis, diagnosis, and management of candidal onychomycosis.
- To highlight the increasing role of Candida species in nail infections.
- To discuss the virulence factors and diagnostic approaches for candidal onychomycosis.
Main Methods:
- Literature review focusing on candidal onychomycosis.
- Analysis of diagnostic methods including direct microscopy, culture, and histopathology.
- Examination of clinical management strategies.
Main Results:
- Candidal onychomycosis is associated with local and systemic immune deficiencies.
- Virulence factors of Candida include adhesion, filamentation, enzyme secretion, and antifungal resistance.
- Diagnosis relies on a combination of clinical presentation and laboratory investigations.
- Management requires a multifaceted approach including immune restoration and antifungal therapy.
Conclusions:
- Candidal onychomycosis is an emerging clinical concern, particularly in vulnerable populations.
- Integrated management strategies are crucial for successful treatment outcomes.
- Preventive measures focusing on nail hygiene and risk factor reduction are essential.
Related Concept Videos
Candidiasis
Fungal Phylum Microsporidia
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Antifungal Agents
Cryptococcal Meningitis
Microbiome of the Eye

